Common Mistakes When Injecting GLP-1 Medications Understanding and avoiding common injection errors can significantly improve treatment outcomes and reduce adverse effects
June 2024: Structure Therapeutics reported positive Phase IIa obesity data for GSBR-1290, an oral non-peptide small-molecule GLP-1 receptor agonist, achieving 6.2% placebo-adjusted mean weight loss at 12 weeks
[26] Carnitine blood levels and muscle stores can become low, which may contribute to anemia, muscle weakness, fatigue, altered levels of blood fats, and heart disorders
These medications can support weight loss, but avoiding unpleasant side effects such as muscle loss and severe constipation requires intentional effort
1 If confirmed, the finding could eventually allow physicians to optimize GLP-1 dosing strategies with cardiovascular outcomes in mind, distinct from weight management goals
Pink Bariatric Gelatin (Sugar-Free Jello Hack) Replace half the hot water with sugar-free strawberry or raspberry gelatin mix (one-quarter of a standard box)